Home › NDC Lookup › RxCUI directory › RxCUI 142113

Mesna 400 MG Oral Tablet — RxCUI 142113

RxNorm drug concept · Semantic clinical drug
RxCUI 142113 Semantic clinical drug · SCD ● Current RxNorm concept 2 FDA products 2 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI142113
Official nameMesna 400 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped2
Package NDCs mapped2
Reported Medicaid activity (SDUD)170 prescriptions · 4 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Mesna: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Great question — mesna isn't your cancer treatment. It's a protective medication given alongside your chemotherapy drug ifosfamide. Ifosfamide breaks down in your body into toxic b...
  • Why am I being given mesna? I thought I was here for chemotherapy.
  • It depends on your treatment schedule — your doctor may use one of two approaches. Some patients receive all doses through an IV line. Others start with an IV dose and then take or...
  • Do I take mesna as a pill or does it go through an IV?
📖 Read our full Mesna guide →

🕸️ Concept Web — How Mesna 400 MG Oral Tablet Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Mesna 400 MG Oral Tablet RxCUI 142113

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Mesna 44
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Mesnex 218330
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Mesna Oral Tablet 372790
    • Mesna Oral Product 1160996
    • Mesna Pill 1160997
    • Mesna Oral Tablet [Mesnex] 368580
    • Mesnex Oral Product 1185038
    • Mesnex Pill 1185039
    • Oral Tablet 317541
    • Oral Product 1151131
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Mesna 400 MG SCDC · 334033
  • Mesna Oral Tablet SCDF · 372790
  • Mesna Oral Product SCDG · 1160996
  • Mesna Pill SCDG · 1160997

Brand-Name Concepts

  • Mesna 400 MG Oral Tablet [Mesnex] SBD · 352210
  • Mesna 400 MG [Mesnex] SBDC · 575932
  • Mesna Oral Tablet [Mesnex] SBDF · 368580
  • Mesnex Oral Product SBDG · 1185038
  • Mesnex Pill SBDG · 1185039
  • Mesnex BN · 218330

📦 FDA Products & Package NDCs

2 products · 2 package NDCs
2 package NDCs map to RxCUI 142113 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
50742-0354-01 1 BLISTER PACK in 1 CARTON (50742-354-01) / 10 TABLET, FILM... MESNA Ingenus Pharmaceuticals, LLC 2025-01-14
67108-3565-09 10 BLISTER PACK in 1 CARTON (67108-3565-9) / 1 TABLET, FILM... MESNEX Baxter Healthcare Company 2002-03-21
Observed labelers: Baxter Healthcare Company (1) · Ingenus Pharmaceuticals, LLC (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.